Nike: Rip The Script
It was all going to plan until footballer’s instincts took over.
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
Did Timothée Chalamet Just Take a Dig at Deceptive Marketing?
Why I’m a fan of this Adidas World Cup ad.
‘Bet Now’: How Wagering Apps’ Push Notification Ads Bombard Consumers
TINA.org joins petition urging FTC to require consent and opt-out for gambling marketing.
Does Gatorade ‘Hydrate Better than Water’?
Lawsuits takes aim at sports drinks’ superior hydration claim.
Phoebe Gates’s Startup Phia Was Just Accused of ‘Cookie Stuffing.’ Here’s What Happens Next
Esther Lian, Inc.com